Singota Solutions, a leading Contract Development and Manufacturing Organization (CDMO) located in Bloomington, Indiana, is excited to announce the expansion of its European services with a new state-of-the-art -40°C and -20°C pallet storage facility near Milan, Italy. This new facility enhances Singota’s already existing capabilities in small batch aseptic filler processes (aseptic filling), aseptic manufacturing solutions, injectable formulation development, GMP compliant warehouse facilities, and cold chain pharmaceutical storage. These advancements reflect Singota’s dedication to meeting the diverse and evolving needs of its global pharmaceutical clients.
Singota Solutions has established a strong presence in the pharmaceutical industry by offering specialized services that ensure the integrity and safety of drug products. The new facility in Rovello Porro, Italy, certified by the Italian Medicines Agency (Agenzia Italiana del Farmaco/AIFA), further strengthens Singota’s commitment to providing top-tier logistics and 3PL solutions. With this expansion, Singota not only enhances its geographical reach but also offers cutting-edge storage capabilities crucial for the stability and efficacy of modern biologic products.
With the addition of this specialized facility, Singota Solutions can now better support clients requiring stringent temperature controls, particularly those developing complex biologics and advanced injectable formulations. The -40°C pallet storage capability, uncommon in the industry, addresses a growing need for stable, ultra-low temperature environments for temperature-sensitive products. Ryan Memmer, Manager of QC and Product Development, emphasizes that this capability isn’t just about logistics—it’s a commitment to preserving product integrity and supporting the demanding requirements of early-phase drug development. This expansion further positions Singota as a proactive partner in managing complex supply chains, providing clients with peace of mind that their products are securely stored and compliant with both European and U.S. standards.
This strategic expansion into the European Union, in addition to Singota’s existing operations in Switzerland, offers significant advantages for clients, including streamlined logistics and reduced customs complexities. By providing advanced storage solutions and maintaining stringent regulatory compliance, Singota Solutions continues to support its clients throughout the drug development pipeline, ensuring high-quality outcomes at every stage.
Read more about this exciting expansion below: